Evidence map›Paper›PMID 37577414›Full record

ArticleFrontiers in microbiology2023

Effects of

Wanpeng Dong, Ting Long, Jinghua Ma, Nan Wu, Weidi Mo, Zhicheng Zhou, Jing Jin, Hongying Zhou, Haixia Ding

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wanpeng DongGuizhou Botanical Garden, Guiyang, China.
Ting LongGuizhou Botanical Garden, Guiyang, China.
Jinghua MaGuizhou Botanical Garden, Guiyang, China.
Nan WuGuizhou Botanical Garden, Guiyang, China.
Weidi MoGuizhou Botanical Garden, Guiyang, China.
Zhicheng ZhouGuizhou Botanical Garden, Guiyang, China.
Jing JinGuizhou Botanical Garden, Guiyang, China.
Hongying ZhouGuizhou Botanical Garden, Guiyang, China.
Haixia DingDepartment of Plant Pathology, College of Agriculture, Guizhou University, Guiyang, China.
Guizhou Botanical Garden · CNGuizhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rose black spot is an economically important disease that significantly decreases flower yield. Fungicide and biological control are effective approaches for controlling rose black spot. The objective of this study was to evaluate the effect of application of biological and chemical control agents, including Methods: In this study, the Results and discussion: Both disease incidence and disease index differed significantly among groups (LKW < GUAL210 < CP < CK), and disease control effect exhibited no significant difference between GUAL210 and LKW (60.96% and 63.86%, respectively). Biological control was superior to chemical control in terms of disease prevention effects and duration, and it significantly increased the number of branches and flowers of rose plants. Ascomycota and Basidiomycota accounted for more than 74% of the total fungal abundance, and the abundance of Ascomycota was highest in CK, followed by GUAL210, CP and LKW, which was consistent with the disease occurrence in each group. The analysis of metabolic pathways showed that the HSERMETANA-PWY in each experimental group was significantly lower than that in control group. The Shannon index in each experimental group was significantly lower than that in control group. PCoA analysis showed that the rhizosphere fungal community structure in each experimental group was significantly different from that in control group.

Indexed as

Bacillus velezensisbiological controlblack spot diseaserose (Rosa chinensis)soil fungal structure

Identifiers

PMID37577414
PMCPMC10415101
OpenAlexW4385294156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.